(Q39670159)

13 September 2017

title

Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels (English)

1 reference

13 September 2017

Guan-Min Jiang

1

1 reference

13 September 2017

Yu-Wen He

2

1 reference

13 September 2017

Rui Fang

3

1 reference

13 September 2017

Ge Zhang

4

1 reference

13 September 2017

Jun Zeng

5

1 reference

13 September 2017

Yan-Mei Yi

6

1 reference

13 September 2017

Shu Zhang

7

1 reference

13 September 2017

Xian-Zhang Bu

8

1 reference

13 September 2017

Shao-Hui Cai

9

1 reference

13 September 2017

Jun Du

10

1 reference

13 September 2017

language of work or name

1 reference

5 August 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S1357272510002682?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

https://api.elsevier.com/content/article/PII:S1357272510002682?httpAccept=text/plain

18 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

International Journal of Biochemistry & Cell Biology

18 June 2024

published in

1 reference

13 September 2017

volume

42

1 reference

13 September 2017

issue

11

1 reference

13 September 2017

page(s)

1840-1846

1 reference

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites

13 September 2017

cites work

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1084/JEM.20020052

Cellular responses to interferon-gamma

1

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

18 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Cooperative role of interferon regulatory factor 1 and p91 (STAT1) response elements in interferon-gamma-inducible expression of human indoleamine 2,3-dioxygenase gene

18 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Involvement of two regulatory elements in interferon-gamma-regulated expression of human indoleamine 2,3-dioxygenase gene

18 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

A novel approach for nasopharyngeal carcinoma treatment uses phenylbutyrate as a protein kinase C modulator: implications for radiosensitization and EBV-targeted therapy

18 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

18 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Methylglyoxal downregulates Raf-1 protein through a ubiquitination-mediated mechanism

18 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Short-chain fatty acids inhibit invasive human colon cancer by modulating uPA, TIMP-1, TIMP-2, mutant p53, Bcl-2, Bax, p21 and PCNA protein expression in an in vitro cell culture model.

18 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

18 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Histone deacetylases and cancer

18 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Interfering with cellular signaling pathways enhances sensitization to combined sodium butyrate and GCV treatment in EBV-positive tumor cells

18 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

18 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications

18 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Gene structure of human indoleamine 2,3-dioxygenase

18 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells

18 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Importance of the two interferon-stimulated response element (ISRE) sequences in the regulation of the human indoleamine 2,3-dioxygenase gene

18 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes

18 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells

18 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Therapeutic efficacy of MUC1-specific cytotoxic T lymphocytes and CD137 co-stimulation in a spontaneous breast cancer model.

18 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

18 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer

18 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells

18 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis

18 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts

18 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element

18 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Mechanisms of type-I- and type-II-interferon-mediated signalling

18 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

A phase 2 study of bortezomib in relapsed, refractory myeloma

18 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase

18 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

NF-kappa B activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFN-gamma and tumor necrosis factor-alpha

18 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism

18 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

Prevention of spontaneous tumor development in a ret transgenic mouse model by ret peptide vaccination with indoleamine 2,3-dioxygenase inhibitor 1-methyl tryptophan

18 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

EGFR tyrosine kinase inhibitor AG1478 inhibits cell proliferation and arrests cell cycle in nasopharyngeal carcinoma cells

18 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BIOCEL.2010.07.020

18 June 2024

Identifiers

1 reference

release_l2rp5ftmunffnfdnteyso7cxdi

13 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l2rp5ftmunffnfdnteyso7cxdi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference